| 1. |
Linabery AM, Ross JA. Trends in childhood cancer incidence in the U. S. (1992-2004)[J]. Cancer, 2008, 112(2): 416-432. DOI: 10.1002/cncr.23169.
|
| 2. |
Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children[J]. N Engl J Med, 2015, 373(16): 1541-1552. DOI: 10.1056/NEJMra1400972.
|
| 3. |
Nguyen K, Devidas M, Cheng SC, et al. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children’s Oncology Group study[J]. Leukemia, 2008, 22(12): 2142-2150. DOI: 10.1038/leu.2008.251.
|
| 4. |
SindalMD, RatnaB, TagareS, et al. Retinal leukemic infiltrates[J/OL]. Ophthalmol Retina, 2023, 7(8): 702[2023-05-05]. https://pubmed.ncbi.nlm.nih.gov/37149803/. DOI: 10.1016/j.oret.2023.04.002.
|
| 5. |
Alzuabi AK, Alanazi TA, Alkharashi A, et al. Bilateral retinal infiltration and ischemia as the first presenting sign of chronic myeloid leukemia: a case report with multimodal imaging[J]. Middle East Afr J Ophthalmol, 2023, 30(2): 121-124. DOI: 10.4103/meajo.meajo_69_23.
|
| 6. |
Sharma T, Grewal J, Gupta S, et al. Ophthalmic manifestations of acute leukaemias: the ophthalmologist’s role[J]. Eye, 2004, 18(7): 663-672. DOI: 10.1038/sj.eye.6701308.
|
| 7. |
Pederzolli M, Giglio F, Cicinelli MV, et al. Case report: Intravitreal methotrexate in intraocular acute lymphoblastic leukemia[J/OL]. Front Oncol, 2022, 12: 951362[2022-08-29]. https://pubmed.ncbi.nlm.nih.gov/36106118/. DOI: 10.3389/fonc.2022.951362.
|
| 8. |
Mello LGM, de Paula Effgen P, Kiefer K. Intravitreal methotrexate for iris and ciliary body relapse in acute lymphoblastic leukemia[J/OL]. J Pediatr Ophthalmol Strabismus, 2018, 55: e16-e19[2018-08-29]. https://pubmed.ncbi.nlm.nih.gov/30180238/. DOI: 10.3928/01913913-20180608-02.
|
| 9. |
Vishnevskia-Dai V, Sella King S, Lekach R, et al. Ocular manifestations of leukemia and results of treatment with intravitreal methotrexate[J/OL]. Sci Rep, 2020, 10(1): 1994[2020-02-06]. https://pubmed.ncbi.nlm.nih.gov/32029770/. DOI: 10.1038/s41598-020-58654-8.
|
